| Cost-effectiveness analysis of HLA-B*58:01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in a Malaysian population |
9 |
| Genetic polymorphisms in candidate genes are not associated with increased vincristine-related peripheral neuropathy in Arab children treated for acute childhood leukemia: a single institution study |
7 |
| NAT2 ultra-slow acetylator and risk of anti-tuberculosis drug-induced liver injury: a genotype-based meta-analysis |
7 |
| CYP2D6 haplotypes with enhancer single-nucleotide polymorphism rs5758550 and rs16947 (*2 allele): implications for CYP2D6 genotyping panels |
6 |
| Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study |
4 |
| Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism |
4 |
| Gene-gene interaction between DRD4 and COMT modulates clinical response to clozapine in treatment-resistant schizophrenia |
4 |
| DNA methylation is associated with improvement in lung function on inhaled corticosteroids in pediatric asthmatics |
4 |
| Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci |
3 |
| Influence of donor liver CYP3A4*20 loss-of-function genotype on tacrolimus pharmacokinetics in transplanted patients |
3 |
| Angiotensin-converting enzyme activity in Cavalier King Charles Spaniels with an ACE gene polymorphism and myxomatous mitral valve disease |
3 |
| The role of genetic polymorphisms in the thymidylate synthase (TYMS) gene in methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia |
3 |
| Gene expression changes in lymphoblastoid cell lines and primary B cells by dexamethasone |
3 |
| A randomized phase II study of S-1 versus capecitabine as first-line chemotherapy in elderly metastatic gastric cancer patients with or without poor performance status: clinical and pharmacogenetic results |
3 |
| International survey of patients undergoing percutaneous coronary intervention and their attitudes toward pharmacogenetic testing |
2 |
| Association of FAM65B, AGBL and CUX2 genetic polymorphisms with susceptibility to antituberculosis drug-induced hepatotoxicity: validation study in a Chinese Han population |
2 |
| Leveraging electronic health records to assess the role of ADRB2 single nucleotide polymorphisms in predicting exacerbation frequency in asthma patients |
2 |
| The effect of the CYP2D6 genotype on the maintenance dose of metoprolol in a chronic Dutch patient population |
2 |
| Targeted ultra-deep sequencing of a South African Bantu-speaking cohort to comprehensively map and characterize common and novel variants in 65 pharmacologically-related genes |
2 |
| Assessing the clinical impact of CYP2C9 pharmacogenetic variation on phenytoin prescribing practice and patient response in an integrated health system |
2 |
| Pharmacogenetic and clinical predictors of response to clopidogrel plus aspirin after acute coronary syndrome in Egyptians |
2 |
| Utility of human leukocyte antigen-B*58:01 genotyping and patient outcomes |
2 |
| Effect of tacrolimus dispositional genetics on acute rejection in the first 2 weeks and estimated glomerular filtration rate in the first 3 months following kidney transplantation |
2 |
| Analytical validity of a genotyping assay for use with personalized antihypertensive and chronic kidney disease therapy |
2 |
| Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events |
2 |
| Differential effect of ABCB1 haplotypes on promoter activity |
2 |
| Ontogeny-related pharmacogene changes in the pediatric liver transcriptome |
2 |
| The association between the SLCO1B apolipoprotein E, and CYP2C9 genes and lipid response to fluvastatin: a meta-analysis |
2 |
| Functional expression of human arylamine N-acetyltransferase NAT1*10 and NAT1*11 alleles: a mini review |
2 |
| Impact of SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of phenylephrine and salbutamol by human SULT1A3 allozymes |
1 |
| N-acetyltransferase 2 enzyme genotype-phenotype discordances in both HIV-negative and HIV-positive Nigerians |
1 |
| Pharmacogenetic analysis of belimumab fails to identify robust genetic predictors of efficacy in lupus |
1 |
| A retrospective investigation of HLA-B*5801 in hyperuricemia patients in a Han population of China |
1 |
| The role of phase I and II genetic polymorphisms, smoking, alcohol and cancer family history, in the risk of developing testicular cancer |
1 |
| Association between HNF4A mutations and bleeding complications in patients with stable international normalized ratio |
1 |
| A multiplex pharmacogenetics assay using the MinION nanopore sequencing device |
1 |
| The relevance of the individual screening for genetic variants in predicting ovarian response |
1 |
| Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children |
1 |
| Role of CYP1A ABCG CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients |
1 |
| Individuals with CYP2C8 and CYP2C9 reduced metabolism haplotypes self-adjusted ibuprofen dose in the Coriell Personalized Medicine Collaborative |
1 |
| Targeted sequencing identifies a missense variant in the BEST3 gene associated with antihypertensive response to hydrochlorothiazide |
1 |
| Associations between TMEM196 polymorphisms and NSAID-exacerbated respiratory disease in asthma |
0 |
| PharmGKB summary: Ondansetron and tropisetron pathways, pharmacokinetics and pharmacodynamics |
0 |
| Race/ethnicity difference in the pharmacogenetics of bilirubin-related atazanavir discontinuation |
0 |
| Analysis of comprehensive pharmacogenomic profiling to impact in-hospital prescribing |
0 |
| Pharmacogenetic variants and response to neoadjuvant single-agent doxorubicin or docetaxel: a study in locally advanced breast cancer patients participating in the NCT00123929 phase 2 randomized trial |
0 |
| Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer |
0 |
| The N680S variant in the follicle-stimulating hormone receptor gene identifies hyperresponders to controlled ovarian stimulation |
0 |
| An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance) |
0 |
| PharmGKB summary: methylphenidate pathway, pharmacokinetics/pharmacodynamics |
0 |
